Tuesday, November 3, 2026

Strengthening U.S.-Korea Nuclear Deterrence: Insights from the 6th NCG Meeting

The U.S. and South Korea held the sixth Nuclear Consultative Group meeting, focusing on nuclear integration and countering North Korea's threats.

Cristiano Ronaldo’s Last World Cup: What Went Wrong for Portugal in 2026?

Cristiano Ronaldo's World Cup journey ends in disappointment as Portugal loses to Spain, marking likely his final tournament appearance.

Kim Ho Joong’s Release: What Fans Can Expect After 2 Years in Prison

Singer Kim Ho Joong is released on parole after serving 2 years for a DUI hit-and-run, with fans hopeful for his recovery and return to music.

Health

How Samsung Medical Center Reduced Waste by 80%: A Game-Changer in ESG Management

Hospitals face pressure to adopt eco-friendly practices due to rising concerns over waste and disposable items impacting the environment.

Q901: The Promising New Hope for Pediatric Brain Tumors – What You Need to Know About This FDA-Approved Therapy

Qurient, the major shareholder of DongKoo Bio&Pharma, received FDA approval for a pediatric brain tumor trial of Q901.

IKS014 vs. Enhertu: Can This New HER2 ADC Drug Revolutionize Breast Cancer Treatment?

IKS014 shows a 50% objective response rate in HER2-positive breast cancer patients previously treated with Enhertu.

IMB-105: The Next Breakthrough in Autoimmune Disease Treatment?

IMBiologics partners with GC Pharma to develop next-generation autoimmune disease treatments.

How MEDTIS is Revolutionizing Remote Healthcare in Asia: Insights from Health On Cloud’s CEO

Trust is essential for Korean medical technology to enter foreign markets, according to Jeon Sang-hoon, CEO of Health On Cloud.
Latest

APR’s Medicube Becomes First K-Beauty Brand to Join Coachella as Official Sponsor

APR's Medicube to sponsor Coachella, showcasing beauty tech and cosmetics to enhance global brand awareness.

APR’s Medicube Becomes First K-Beauty Brand to Join Coachella as Official Sponsor

APR's Medicube brand will sponsor Coachella, showcasing beauty tech and products to enhance global brand awareness.

Samsung Biologics Partners with Eli Lilly: How This Open Innovation Hub Will Transform K-Bio by 2027

Samsung Biologics partners with Eli Lilly to create a biotech innovation hub in Korea, enhancing growth opportunities for local firms.

New Fat Reduction Injection Shows 73.7% Success in Phase 3 Trial

AMIPHARM reveals promising phase 3 results for AYP-101, a fat reduction injection, at IMCAS 2026, targeting submental fat safely.

KIMES 2026: How South Korea’s Medical Device Industry is Poised for Global Expansion

KIMES 2026 showcases Korea's medical device sector, highlighting digital growth and global expansion opportunities for domestic companies.

New Diabetes Treatment: Chong Kun Dang’s Dubiempol Sustained Release Tablet Approved for Type 2 Diabetes in Korea

Chong Kun Dang's type 2 diabetes treatment, Dubiempol, gains approval, offering a new option for patients with uncontrolled blood sugar.

How This New Blood Test Using Nanotechnology Could Change Brain Disease Monitoring Forever

South Korean researchers developed a blood test to track brain disease progression, potentially replacing imaging scans for monitoring.

How the New MOU Between Financial and Medical Institutions Will Transform Care for the Underprivileged

A new support system links community finance with public healthcare to aid financially vulnerable populations in accessing medical assistance.

Unlocking the Future of Healthcare: How Dong-A ST and Dou are Revolutionizing AI Solutions in 2026

Dong-A ST partners with Dou for AI solutions to enhance digital healthcare and improve patient experiences in hospitals nationwide.

SleepQ vs. Traditional Medications: Which is the Future of Insomnia Treatment?

Welt aims to complete clinical trials for its SleepQ insomnia device by year-end, targeting listing on Germany's DiGA reimbursement system.

Lotte Biologics at DCAT Week 2026: Unveiling Strategic Collaborations in Global CDMO

Lotte Biologics will attend DCAT Week in New York to pursue global CDMO partnerships and showcase its production capabilities.

Samsung Biologics CEO John Rim Poised for Third Term: What This Means for the Global CDMO Market in 2026

John Rim of Samsung Biologics aims for a third term, leading record growth and expansion into next-gen therapies amid global challenges.

Neurophet AQUA AD Plus: Revolutionizing Alzheimer’s Diagnosis with AI at AD/PD 2026

Neurophet showcased its AI solutions for Alzheimer's at AD/PD 2026, aiming to foster collaborations in treatment development.

Dongkoo Bio&Pharma Invests 1 Billion KRW in GenomAndCompany: What This Means for ADC Drug Development

Dongkoo Bio&Pharma invests 1 billion KRW in Genome & Company to enhance antibody and ADC drug development strategies.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.